These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 3206581)

  • 21. A four generation study of familial dysalbuminemic hyperthyroxinemia: diagnosis in the presence of an acquired excess of thyroxine-binding globulin.
    Yeo PP; Yabu Y; Etzkorn JR; Rajatanavin R; Braverman LE; Ingbar SH
    J Endocrinol Invest; 1987 Feb; 10(1):33-8. PubMed ID: 3110251
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Congenital hypothyroidism in a child with unsuspected familial dysalbuminemic hyperthyroxinemia caused by a mutation (R218H) in the human albumin gene.
    Pohlenz J; Sadow PM; Koffler T; Schönberger W; Weiss RE; Refetoff S
    J Pediatr; 2001 Dec; 139(6):887-91. PubMed ID: 11743520
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Mutations in a specific human serum albumin thyroxine binding site define the structural basis of familial dysalbuminemic hyperthyroxinemia.
    Petersen CE; Ha CE; Jameson DM; Bhagavan NV
    J Biol Chem; 1996 Aug; 271(32):19110-7. PubMed ID: 8702585
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Fluorescence investigations of albumin from patients with familial dysalbuminemic hyperthyroxinemia.
    Dughi C; Bhagavan NV; Jameson DM
    Photochem Photobiol; 1993 Mar; 57(3):416-9. PubMed ID: 8475173
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Coexistence of familial dysalbuminemic hyperthyroxinemia with familial hypercholesterolemia and multiple lipoprotein type hyperlipidemia.
    Premachandra BN; Wolfe B; Williams IK
    Am J Med; 1988 Feb; 84(2):345-51. PubMed ID: 3407659
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Structural investigations of a new familial dysalbuminemic hyperthyroxinemia genotype.
    Petersen CE; Ha CE; Harohalli K; Park DS; Feix JB; Isozaki O; Bhagavan NV
    Clin Chem; 1999 Aug; 45(8 Pt 1):1248-54. PubMed ID: 10430791
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Detection of protein binding abnormalities in euthyroid hyperthyroxinemia.
    George PM; Sheat JM; Palmer BN
    Clin Chem; 1988 Sep; 34(9):1745-8. PubMed ID: 3416422
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The effects of danazol on a patient with familial dysalbuminemic hyperthyroxinemia.
    Katz N; Toney MO; Heironimus JD
    Clin Nucl Med; 1993 Jan; 18(1):53-5. PubMed ID: 8422721
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Familial dysalbuminemic hyperthyroxinemia in a Swiss family caused by a mutant albumin (R218P) shows an apparent discrepancy between serum concentration and affinity for thyroxine.
    Pannain S; Feldman M; Eiholzer U; Weiss RE; Scherberg NH; Refetoff S
    J Clin Endocrinol Metab; 2000 Aug; 85(8):2786-92. PubMed ID: 10946882
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Mutagenesis studies of thyroxine binding to human serum albumin define an important structural characteristic of subdomain 2A.
    Petersen CE; Ha CE; Harohalli K; Park D; Bhagavan NV
    Biochemistry; 1997 Jun; 36(23):7012-7. PubMed ID: 9188698
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Identification of a human serum albumin species associated with familial dysalbuminemic hyperthyroxinemia.
    Rushbrook JI; Becker E; Schussler GC; Divino CM
    J Clin Endocrinol Metab; 1995 Feb; 80(2):461-7. PubMed ID: 7852505
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Etiology and outcome of non-estrogen associated hyperthyroxinemia in euthyroid patients at the San Juan City Hospital.
    Alegre M; Meléndez EG; Colón G
    Bol Asoc Med P R; 1996; 88(1-3):12-5. PubMed ID: 8885441
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Studies on the nature of iodothyronine binding in familial dysalbuminemic hyperthyroxinemia.
    Divino CM; Schussler GC
    J Clin Endocrinol Metab; 1990 Jul; 71(1):98-104. PubMed ID: 2370303
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Mutants and molecular dockings reveal that the primary L-thyroxine binding site in human serum albumin is not the one which can cause familial dysalbuminemic hyperthyroxinemia.
    Kragh-Hansen U; Minchiotti L; Coletta A; Bienk K; Galliano M; Schiøtt B; Iwao Y; Ishima Y; Otagiri M
    Biochim Biophys Acta; 2016 Apr; 1860(4):648-60. PubMed ID: 26777880
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A case of familial euthyroid hyperthyroxinemia--thyroid hormone resistance syndrome?
    Garg MK; Saini JS
    J Assoc Physicians India; 1999 Mar; 47(3):340-1. PubMed ID: 10999134
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A novel missense mutation in codon 218 of the albumin gene in a distinct phenotype of familial dysalbuminemic hyperthyroxinemia in a Japanese kindred.
    Wada N; Chiba H; Shimizu C; Kijima H; Kubo M; Koike T
    J Clin Endocrinol Metab; 1997 Oct; 82(10):3246-50. PubMed ID: 9329347
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Case report: familial dysalbuminemic hyperthyroxinemia--a variant.
    Goldman MH; Klinges K
    J Med Soc N J; 1984 May; 81(5):404-5. PubMed ID: 6590861
    [No Abstract]   [Full Text] [Related]  

  • 38. [Hyperthyroxinemia and clinical euthyroidism. Report of one case].
    López JM; Mosso L; Campino C
    Rev Med Chil; 1999 Feb; 127(2):197-201. PubMed ID: 10436700
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Familial dysalbuminemic hyperthyroxinemia associated with multinodular goiter and elevated radioiodine uptake. A case report.
    Toney MO; Heironimus JD
    Clin Nucl Med; 1991 Dec; 16(12):926-7. PubMed ID: 1769174
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Expression of a human serum albumin variant with high affinity for thyroxine.
    Petersen CE; Ha CE; Mandel M; Bhagavan NV
    Biochem Biophys Res Commun; 1995 Sep; 214(3):1121-9. PubMed ID: 7575519
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.